• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AGEN

AGEN

Agenus Inc.

NASDAQHealthcareBiotechnologyUS

USD3.22

-0.16 (-4.73%)

Rating:C+

Company Profile

CEO

Garo H. Armen

IPO Date

2000-02-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.36

Prev. Close

$3.38

Day Low

$3.21

Day High

$3.42

52W Low

$2.71

52W High

$7.34

Market Cap

$0.13B

Volume

0.47M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.2%

Avg Negative

7.0%

Avg Neutral

59.0%

News Feed

MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

GlobeNewsWire·7/28/2021·↓ negative

Why Agenus Stock Sank on Tuesday

The Motley Fool·7/27/2021·↓ negative

Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021

GlobeNewsWire
·7/7/2021
·↑ positive

Moving Average Crossover Alert: Agenus (AGEN)

Zacks Investment Research·7/6/2021·↑ positive

Agenus (AGEN) Is a Great Choice for "Trend" Investors, Here's Why

Zacks Investment Research·7/5/2021·↑ positive

AGEN Stock Price Increased 6.4%: Why It Happened

Pulse2·6/18/2021·↑ positive

Why Agenus Stock Is Marching Higher Today

The Motley Fool·6/17/2021·↑ positive

Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer

Benzinga·6/17/2021·↑ positive

Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer

GlobeNewsWire·6/17/2021·↑ positive

Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist

PennyStocks·6/8/2021·↑ positive